Cargando…
Whole genome sequence analysis of the first reported isolate of Salmonella Agona carrying blaCTX-M-55 gene in Brazil
This study analyzes the genomic findings of the first report of Salmonella isolate carrying the bla(CTX-M-55) gene, recovered from a bacteremic patient from Brazil. A bacterial isolate positive for the bla(CTX-M-55) gene was submitted to antimicrobial susceptibility testing by disk diffusion and eps...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911770/ https://www.ncbi.nlm.nih.gov/pubmed/36759682 http://dx.doi.org/10.1038/s41598-023-29599-5 |
Sumario: | This study analyzes the genomic findings of the first report of Salmonella isolate carrying the bla(CTX-M-55) gene, recovered from a bacteremic patient from Brazil. A bacterial isolate positive for the bla(CTX-M-55) gene was submitted to antimicrobial susceptibility testing by disk diffusion and epsilometric test. Whole genome sequencing was performed using Illumina technology. Conjugation assay was performed; plasmid sizes determined by S1-PFGE and plasmid content were investigated by hybrid assembly after MinION long reads sequencing. Isolate 288_18 was identified as sequence type ST13, resistant to ampicillin, cefotaxime, ceftazidime, cefepime, ceftriaxone, and aztreonam. A transferable IncFII plasmid sized approximately 67 kb was found to carry the bla(TEM-1) and bla(CTX-M-55) in a module consisting of IS26-bla(TEM-1B)-WbuC-bla(CTX-M-55)-IS26. In addition, an 117 kb IncI1plasmid was also identified in the 288_18 isolate, but without additional resistance genes. To the best of our knowledge, this is the first report of bla(CTX-M-55) in Salmonella isolated from human infection in Brazil. The occurrence of bla(CTX-M-55) in the IncFII epidemic plasmid in a relevant clinical human isolate of Salmonella Agona underscores the urgent need for enhanced and effective continuous surveillance for controlling its dissemination. |
---|